Works matching IS 1462-8902 AND VI 25 AND IP 9 AND DT 2023
Results: 42
Cover Image.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 1, doi. 10.1111/dom.15242
- By:
- Publication type:
- Article
Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1a, blinded, placebo‐controlled, randomized, single‐ and multiple‐ascending‐dose study in healthy participants.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2634, doi. 10.1111/dom.15184
- By:
- Publication type:
- Article
The novel GIP, GLP‐1 and glucagon receptor agonist retatrutide delays gastric emptying.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2784, doi. 10.1111/dom.15167
- By:
- Publication type:
- Article
Real‐world study of ethnic differences in glycaemic control and clinical characteristics among insulin‐naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2756, doi. 10.1111/dom.15165
- By:
- Publication type:
- Article
Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2743, doi. 10.1111/dom.15164
- By:
- Publication type:
- Article
Risk of breakthrough SARS‐CoV‐2 infection and clinical outcomes among vaccinated patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2734, doi. 10.1111/dom.15163
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long‐acting glucagon analogue HM15136 in overweight and obese patients with co‐morbidities.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2723, doi. 10.1111/dom.15162
- By:
- Publication type:
- Article
Comparing the technical reliability and insulin dosing of a "do‐it‐yourself artificial pancreas" with a commercial hybrid closed‐loop system in a "shadow‐mode" scenario: An exploratory study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2780, doi. 10.1111/dom.15161
- By:
- Publication type:
- Article
Effects of dietary quality, physical activity and weight loss on glucose homeostasis in persons with and without prediabetes in the PREMIER trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2714, doi. 10.1111/dom.15160
- By:
- Publication type:
- Article
A micro‐randomized pilot study to examine the impact of just‐in‐time nudging on after‐dinner snacking in adults with type 2 diabetes: A study protocol.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2439, doi. 10.1111/dom.15159
- By:
- Publication type:
- Article
Cost‐utility of real‐time continuous glucose monitoring versus self‐monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2704, doi. 10.1111/dom.15158
- By:
- Publication type:
- Article
Serum uric acid lowering and effects of sodium‐glucose cotransporter‐2 inhibitors on gout: A meta‐analysis and meta‐regression of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2697, doi. 10.1111/dom.15157
- By:
- Publication type:
- Article
Diabetes, fasting blood glucose and the efficacy of remote ischaemic conditioning: A secondary analysis of the RICAMIS trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2689, doi. 10.1111/dom.15156
- By:
- Publication type:
- Article
Trends and disparities in telehealth use among Louisiana Medicaid beneficiaries with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2680, doi. 10.1111/dom.15155
- By:
- Publication type:
- Article
Weight change and risk of obesity‐related complications: A retrospective population‐based cohort study of a UK primary care database.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2669, doi. 10.1111/dom.15154
- By:
- Publication type:
- Article
Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study).
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2659, doi. 10.1111/dom.15153
- By:
- Publication type:
- Article
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2650, doi. 10.1111/dom.15152
- By:
- Publication type:
- Article
The role of adiponectin for immune cell function in metabolic diseases.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2427, doi. 10.1111/dom.15151
- By:
- Publication type:
- Article
Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1b, multicentre, blinded, placebo‐controlled, randomized, multiple‐ascending‐dose study in people with type 2 diabetes
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2642, doi. 10.1111/dom.15150
- By:
- Publication type:
- Article
Surfing the waves of the COVID‐19 pandemic with diabetes mellitus: Analysis of changes in the diabetes therapy, metabolism and physical activity of 92 992 people living with type 1 or type 2 diabetes from the German DPV registry.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2774, doi. 10.1111/dom.15149
- By:
- Publication type:
- Article
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2626, doi. 10.1111/dom.15148
- By:
- Publication type:
- Article
Glycaemic patterns of male professional athletes with type 1 diabetes during exercise, recovery and sleep: Retrospective, observational study over an entire competitive season.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2616, doi. 10.1111/dom.15147
- By:
- Publication type:
- Article
Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2605, doi. 10.1111/dom.15146
- By:
- Publication type:
- Article
Acute pharmacodynamic responses to exenatide: Drug‐induced increases in insulin secretion and glucose effectiveness.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2586, doi. 10.1111/dom.15143
- By:
- Publication type:
- Article
Perceptions, behaviours and potential barriers to effective obesity care. Results from the ACTION‐DK study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2595, doi. 10.1111/dom.15144
- By:
- Publication type:
- Article
Associations of diabetes, prediabetes and diabetes duration with the risk of chronic obstructive pulmonary disease: A prospective UK Biobank study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2575, doi. 10.1111/dom.15142
- By:
- Publication type:
- Article
Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6‐month long interventional study
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2561, doi. 10.1111/dom.15141
- By:
- Publication type:
- Article
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2553, doi. 10.1111/dom.15140
- By:
- Publication type:
- Article
The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2545, doi. 10.1111/dom.15139
- By:
- Publication type:
- Article
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2535, doi. 10.1111/dom.15138
- By:
- Publication type:
- Article
Advancing therapy in people with suboptimally controlled basal insulin‐treated type 2 diabetes: Subanalysis of the SoliMix trial in participants in Latin American countries.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2526, doi. 10.1111/dom.15125
- By:
- Publication type:
- Article
Efficacy and safety of carbohydrate restriction in patients with type 1 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2770, doi. 10.1111/dom.15124
- By:
- Publication type:
- Article
Sulfatide inhibits fibroblast growth, activation and oxidative stress induced by ectopic insulin.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2514, doi. 10.1111/dom.15123
- By:
- Publication type:
- Article
Stabilization of kidney function and reduction in heart failure events with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis and meta‐regression analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2505, doi. 10.1111/dom.15122
- By:
- Publication type:
- Article
Comparative efficacy and safety of Gla‐300 versus IDegAsp in insulin‐naïve people with type 2 diabetes mellitus uncontrolled on oral anti‐diabetics.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2495, doi. 10.1111/dom.15121
- By:
- Publication type:
- Article
Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID‐19 patients: Comparison with influenza and pre‐pandemic data.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2482, doi. 10.1111/dom.15120
- By:
- Publication type:
- Article
The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2765, doi. 10.1111/dom.15119
- By:
- Publication type:
- Article
Impact of pre‐existing type 2 diabetes with and without cardiovascular disease on patients with COVID‐19.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2464, doi. 10.1111/dom.15069
- By:
- Publication type:
- Article
Association between glycaemia risk index (GRI) and diabetic retinopathy in type 2 diabetes: A cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2457, doi. 10.1111/dom.15068
- By:
- Publication type:
- Article
First‐in‐human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2447, doi. 10.1111/dom.15066
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2425, doi. 10.1111/dom.14756
- Publication type:
- Article
Baseline determinants of remission of type 2 diabetes in response to short‐term insulin‐based therapy: The pivotal role of beta‐cell function.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2473, doi. 10.1111/dom.15073
- By:
- Publication type:
- Article